Literature DB >> 20637978

Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.

Emmanouil Fokas1, Jörg Hänze, Florentine Kamlah, Bastian G Eul, Nico Lang, Boris Keil, Johannes T Heverhagen, Rita Engenhart-Cabillic, Hanxiang An, Frank Rose.   

Abstract

PURPOSE: Hypoxia is a major determinant of tumor radiosensitivity, and microenvironmental changes in response to ionizing radiation (IR) are often heterogenous. We analyzed IR-dependent changes in hypoxia and perfusion in A549 human lung adenocarcinoma xenografts.
MATERIALS AND METHODS: Immunohistological analysis of two exogenously added chemical hypoxic markers, pimonidazole and CCI-103F, and of the endogenous marker Glut-1 was performed time dependently after IR. Tumor vessels and apoptosis were analyzed using CD31 and caspase-3 antibodies. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and fluorescent beads (Hoechst 33342) were used to monitor vascular perfusion.
RESULTS: CCI-103F signals measuring the fraction of hypoxic areas after IR were significantly decreased by approximately 50% when compared with pimonidazole signals, representing the fraction of hypoxic areas from the same tumors before IR. Interestingly, Glut-1 signals were significantly decreased at early time point (6.5 h) after IR returning to the initial levels at 30.5 h. Vascular density showed no difference between irradiated and control groups, whereas apoptosis was significantly induced at 10.5 h post-IR. DCE-MRI indicated increased perfusion 1 h post-IR.
CONCLUSIONS: The discrepancy between the hypoxic fractions of CCI-103F and Glut-1 forces us to consider the possibility that both markers reflect different metabolic alterations of tumor microenvironment. The reliability of endogenous markers such as Glut-1 to measure reoxygenation in irradiated tumors needs further consideration. Monitoring tumor microvascular response to IR by DCE-MRI and measuring tumor volume alterations should be encouraged. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637978     DOI: 10.1016/j.ijrobp.2010.01.060

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.

Authors:  Huagang Hou; Sriram P Mupparaju; Jean P Lariviere; Sassan Hodge; Jiang Gui; Harold M Swartz; Nadeem Khan
Journal:  Radiat Res       Date:  2013-02-07       Impact factor: 2.841

Review 2.  Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors?

Authors:  Sergey V Kozin; Dan G Duda; Lance L Munn; Rakesh K Jain
Journal:  J Natl Cancer Inst       Date:  2012-05-09       Impact factor: 13.506

3.  Use of 3-D Contrast-Enhanced Ultrasound to Evaluate Tumor Microvasculature After Nanoparticle-Mediated Modulation.

Authors:  Jihun Kwon; Rajalekha M Rajamahendiran; Needa A Virani; Sijumon Kunjachan; Erin Snay; Max Harlacher; Marios Myronakis; Shinichi Shimizu; Hiroki Shirato; Tomasz J Czernuszewicz; Ryan Gessner; Ross Berbeco
Journal:  Ultrasound Med Biol       Date:  2019-11-04       Impact factor: 2.998

4.  Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1.

Authors:  Johanna Dalmo; Johan Spetz; Mikael Montelius; Britta Langen; Yvonne Arvidsson; Henrik Johansson; Toshima Z Parris; Khalil Helou; Bo Wängberg; Ola Nilsson; Maria Ljungberg; Eva Forssell-Aronsson
Journal:  EJNMMI Res       Date:  2017-01-05       Impact factor: 3.138

5.  Tumor physiological changes during hypofractionated stereotactic body radiation therapy assessed using multi-parametric magnetic resonance imaging.

Authors:  Heling Zhou; Zhang Zhang; Rebecca Denney; Jessica S Williams; Jeni Gerberich; Strahinja Stojadinovic; Debabrata Saha; John M Shelton; Ralph P Mason
Journal:  Oncotarget       Date:  2017-06-06

6.  Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation.

Authors:  Katja Hattar; Rajkumar Savai; Florentine S B Subtil; Jochen Wilhelm; Anja Schmall; Dagmar S Lang; Torsten Goldmann; Bastian Eul; Gabriele Dahlem; Ludger Fink; Ralph-Theo Schermuly; Gamal-Andre Banat; Ulf Sibelius; Friedrich Grimminger; Ekkehard Vollmer; Werner Seeger; Ulrich Grandel
Journal:  Cancer Immunol Immunother       Date:  2012-08-26       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.